Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model.
Imanishi M, Yamakawa Y, Fukushima K, Ikuto R, Maegawa A, Izawa-Ishizawa Y, Horinouchi Y, Kondo M, Kishuku M, Goda M, Zamami Y, Takechi K, Chuma M, Ikeda Y, Tsuchiya K, Fujino H, Tsuneyama K, Ishizawa K.
Imanishi M, et al. Among authors: kondo m.
Naunyn Schmiedebergs Arch Pharmacol. 2020 Jul;393(7):1239-1250. doi: 10.1007/s00210-020-01859-5. Epub 2020 Apr 19.
Naunyn Schmiedebergs Arch Pharmacol. 2020.
PMID: 32307577